We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$735M
AUM Growth
+$44.9M
Cap. Flow
+$20.2M
Cap. Flow %
2.75%
Top 10 Hldgs %
19.62%
Holding
367
New
107
Increased
51
Reduced
96
Closed
84

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$17.3M
2
VFC icon
VF Corp
VFC
+$8.46M
3
VIAB
Viacom Inc. Class B
VIAB
+$7.98M
4
ABT icon
Abbott
ABT
+$7.08M
5
MDT icon
Medtronic
MDT
+$7.03M

Sector Composition

Rank Sector Weight
1 Financials 16.98%
2 Technology 14.38%
3 Healthcare 14.23%
4 Industrials 12.47%
5 Consumer Discretionary 11.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNET icon
226
TriNet
TNET
$3.14B
$464K 0.06%
18,099
-35,583
-66% -$807K
ELGX
227
DELISTED
Endologix Inc
ELGX
$463K 0.06%
8,101
+6,083
+301% +$557K
NXGN
228
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$462K 0.06%
35,148
-24,559
-41% -$315K
DF
229
DELISTED
Dean Foods Company
DF
$454K 0.06%
20,842
-48,814
-70% -$928K
IMPV
230
DELISTED
Imperva, Inc.
IMPV
$434K 0.06%
+11,294
New +$459K
PRTK
231
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$433K 0.06%
28,110
+374
+1% +$4.86K
SUM
232
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$426K 0.06%
18,475
-33,315
-64% -$699K
SHLM
233
DELISTED
Schulman (A.) Inc
SHLM
$423K 0.06%
12,655
-33,932
-73% -$1.08M
SSYS icon
234
Stratasys
SSYS
$774M
$421K 0.06%
25,466
-6,924
-21% -$136K
AHRT
235
AH Realty Trust
AHRT
$517M
$403K 0.05%
27,685
-7,724
-22% -$107K
ACIC icon
236
American Coastal Insurance
ACIC
$493M
$365K 0.05%
24,124
BMY icon
237
Bristol-Myers Squibb
BMY
$132B
$361K 0.05%
6,169
-186,836
-97% -$10.2M
STML
238
DELISTED
Stemline Therapeutics, Inc.
STML
$361K 0.05%
33,725
EFOR
239
Everforth Inc
EFOR
$1.32B
$360K 0.05%
+8,152
New +$324K
DFRG
240
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$360K 0.05%
21,171
KS
241
DELISTED
KapStone Paper and Pack Corp.
KS
$351K 0.05%
15,911
-68,900
-81% -$1.4M
JIVE
242
DELISTED
Jive Software, Inc.
JIVE
$346K 0.05%
+79,628
New +$322K
HUBG icon
243
HUB Group
HUBG
$2.92B
$341K 0.05%
15,610
MYCC
244
DELISTED
ClubCorp Holdings, Inc.
MYCC
$336K 0.05%
+23,392
New +$311K
TRTN
245
DELISTED
Triton International Limited
TRTN
$330K 0.04%
+20,866
New +$334K
SRCI
246
DELISTED
SRC Energy Inc
SRCI
$323K 0.04%
36,297
-32,913
-48% -$268K
MGNI icon
247
Magnite
MGNI
$3.55B
$320K 0.04%
43,060
+11,755
+38% +$91.6K
STT icon
248
State Street
STT
$50.7B
$320K 0.04%
+4,123
New +$310K
ZEN
249
DELISTED
ZENDESK INC
ZEN
$316K 0.04%
+14,908
New +$361K
AMGN icon
250
Amgen
AMGN
$222B
$309K 0.04%
+2,112
New +$318K

Similar funds

Stoneridge Investment Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Stoneridge Investment Partners held 367 positions worth $735M, up 6.5% from $690M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Stoneridge Investment Partners's Q4 2016 filing shows 107 new, 51 increased, 96 reduced and 84 closed positions. Its largest new stake was VF Corp: 163,221 shares worth $8.2M. The largest sale was Bristol-Myers Squibb, an estimated $10.2M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Stoneridge Investment Partners's largest Q4 2016 buy was VF Corp: 163,221 shares worth $8.2M.
  • Stoneridge Investment Partners added most to TJX Companies in Q4 2016, an estimated $17.3M increase.
  • Stoneridge Investment Partners's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $10.2M.
  • Stoneridge Investment Partners fully exited Carnival Corporation Ltd in Q4 2016, selling an estimated $7.84M.
  • Stoneridge Investment Partners's ten largest holdings make up 20% of its $735M portfolio in Q4 2016.
  • Stoneridge Investment Partners opened 107 new positions and closed 84 in Q4 2016.
  • Stoneridge Investment Partners's portfolio value rose 6.5% quarter-over-quarter to $735M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2016, filed 27 Jan 2017.